Advent International

Advent International

Advent International is an American global private equity firm.

Founded in 1984, Advent International is a private equity firm based in Boston, Massachusetts. The firm seeks to invest in the retail, insurance, and media sectors.

Advent International has offices on four continents, and they have established a globally integrated team of more than 195 investment professionals, focused on buyouts and growth equity investments in five core sectors. Since initiating their private equity strategy in 1989, they have invested $44 billion in over 345 private equity investments across 41 countries, and as of December 31, 2018, managed $36 billion in assets. Today, as they did more than 30 years ago, they seek to invest in well-positioned companies and partner with management teams to create value through sustained revenue and earnings growth.

Timeline

March 4, 2019

Evonik signs an agreement to sell its Methacrylates business to Advent International for €3 billion.

Funded Companies

Company
Description
Website
Industry
Location

Trustpilot offers a validated and open review community through which consumers can learn about a business and how others have experienced their product and service, and businesses can understand consumers engagement with their products.

A company developing biologically active compounds and drug candidates

Fleetcor is a Norcross, Georgia-based company.

P2 Energy Solutions is a Denver-based company.

Quest Global is a Singapore-based company.

10 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Adelino Gomes

Employee

Aditya Kamath

Employee

Alex Kohl

Employee

Alex Lundgren

Employee

Alexis de Clermont-Tonnerre

Employee

Amit Shah

Employee

amit shah

Employee

Angelo Brisimitzakis

Employee

Anna Zawilinska

Employee

Atul Chatur

Employee

Brady Newman

Employee

Branko Jelicic

Employee

Brenno Raiko

Employee

Bryan Meyerhofer

Investor

Burcu Gobuluk

Employee

Cailleach De Weingart-Ryan

Employee

Daniel Terepins

Employee

Devansh Dalmia

Employee

Dhruvi Shah

Employee

Diego Serebrisky

Employee

Don Wu

Employee

Douglas Hallstrom

Employee

Eduardo Rios

Employee

Eric John Buckley

Employee

Girish Sankar

Employee

Page 1 of 3

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
BioSpace
May 26, 2020
BioSpace
BioDuro, LLC, a leading drug discovery and development services organization, announced today the availability of two new preclinical models for Non-alcoholic steatohepatitis (NASH) that highly resemble clinical progression of the disease and do so in a matter of 2-3 months.
BBC News
December 21, 2019
BBC News
Critics say there are still national security questions over the sale of Cobham to a US equity firm.
Reuters Editorial
December 21, 2019
U.S.
The British government has approved Advent International's $5 billion purchase of defense company Cobham Plc after the U.S. private equity group offered a number of commitments to address national security concerns.
Ranju Sarkar
November 18, 2019
@bsindia
Read more about Advent International to buy majority stake in Bharat Serums and Vaccines on Business Standard. OrbiMed PE and Kotak PE, two private equity firms that previously held minority positions in Bharat Serums, will fully exit their investments in the company
Ranju Sarkar
October 4, 2019
@bsindia
Read more about PE firm Advent acquires women's innerwear brand Enamor in Rs 320 cr deal on Business Standard. The transaction is Advent's eighth investment in India in the past four years and its fourth in the consumer goods sector during the same period
Sean Farrell
September 18, 2019
the Guardian
An international air event at RAF Fairford, Gloucestershire. Cobham operates in more than 100 countries. Photograph: Graham Taylor/RAF
Deborshi Chaki
Invalid Date
DealStreetAsia
Promoters of Bharat Serums and Vaccines Ltd are in initial talks with private equity (PE) firms to sell a controlling stake for around $500 million.
Dearbail Jordan
March 19, 2019
BBC News
The UK's richest man, and now owner of a cycling team, has built a multi-billion pound business by buying unloved assets.
March 4, 2019
WebWire
, , , , • Consistent strategy execution to focus on specialty chemicals, , • Attractive selling price of €3 billion is 8.5 times the business' EBITDA, , • Excellent development opportunities for Methacrylate business, , , , , , Evonik has today signed an agreement to sell its Methacrylates business to Advent International for €3 billion. The selling price (enterprise value) is 8.5 times the business' EBITDA. The transaction is subject to approval by the authorities in several countries and is expected...

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.